SensoLyte® 440 West Nile Virus Protease Assay Kit Fluorimetric - 1 kit
- Cat.Number : AS-72079
- Manufacturer Ref. :
-
Availability :
In stock
- Shipping conditions : Ice fees will apply
Alternative choices
West Nile virus (WNV) causes severe neurological disease and fatalities in both human and animal hosts. There is currently no effective vaccine or antiviral drug to protect against WNV infection. The West Nile virus NS3 protease, essential for the proteolytic processing of the viral polyprotein precursor, is a promising target for the development of anti-WNV drugs.
The SensoLyte® 440 West Nile Virus Protease Assay Kit provides a convenient homogenous assay for high throughput screening of WNV protease inhibitors and for continuous assay of NS3 protease activity using a fluorogenic Pyr-RTKR-AMC peptide. Upon NS3 protease cleavage, Pyr-RTKR-AMC generates the AMC fluorophore that has bright blue fluorescence and can be detected at excitation/emission=380 nm/460 nm.
Specifications
Packaging | |
Kits components |
|
---|---|
Properties | |
Absorbance (nm) |
|
Emission (nm) |
|
Storage & stability | |
Storage Conditions |
|
Activity | |
Application | |
Biomarker Target | |
Detection Method | |
Research Area | |
Usage |
|
Downloads
You may also be interested in the following product(s)
Citations
Discovery, Synthesis, and in vitro Evaluation of West Nile Virus Protease Inhibitors Based on the 9,10‐Dihydro‐3H,4aH‐1,3,9,10a‐tetraazaphenanthren‐4‐one Scaffold
Chem Med Chem . 2010 Apr 30 ; 7(7) 1210 | DOI : https://doi.org/10.1002/cmdc.201200136
- S. Samanta
Crystal Structure of a Novel Conformational State of the Flavivirus NS3 Protein: Implications for Polyprotein Processing and Viral Replication
J Virol. . 2009 Sep 30 ; 83(24) 12895 | DOI : 10.1128/JVI.00942-09
- R. Assenberg,